Clinical Trials Logo

Filter by:
NCT ID: NCT05129332 Withdrawn - Dyspareunia Clinical Trials

Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia

Start date: August 3, 2022
Phase: N/A
Study type: Interventional

In this randomized controlled trial, the investigators will assess the difference in mean patient-reported pain scores and sexual function between women with gynecologic or breast cancers experiencing dyspareunia (painful intercourse) who are assigned to vaginal dilator use with vaginal moisturizer (Intervention Group, n = 29) compared to vaginal moisturizer alone (Control Group, n = 29) over 16 weeks.

NCT ID: NCT05128344 Withdrawn - Spasms, Infantile Clinical Trials

A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Start date: April 2023
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy of AMZ002 compared to Vigabatrin in participants with newly diagnosed infantile spasms (IS).

NCT ID: NCT05127785 Withdrawn - Heart Failure Clinical Trials

Frailty in Individuals With Advanced Heart Failure Part 2

Start date: November 9, 2021
Phase:
Study type: Observational

To investigate how measures of frailty, assessed during occupational therapy (OT) evaluation and intervention impact decision for advanced heart failure (HF) therapies and postoperative outcomes.

NCT ID: NCT05123508 Withdrawn - Scars Clinical Trials

Treatment of Breast Lift/Reduction Scars

Start date: June 30, 2021
Phase: N/A
Study type: Interventional

Laser and light treatment for surgical scars following breast lifts/reductions

NCT ID: NCT05121402 Withdrawn - Ulcerative Colitis Clinical Trials

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

Start date: December 30, 2022
Phase: Phase 2
Study type: Interventional

A study to investigate the safety and efficacy of TLL018 compared with placebo in subjects with moderate to severe ulcerative colitis.

NCT ID: NCT05119712 Withdrawn - Clinical trials for Ankylosing Spondylitis

Terbinafine Treatment of Axial Spondyloarthropathy

FUN
Start date: March 9, 2021
Phase: Early Phase 1
Study type: Interventional

This is a pilot study to determine if further research is warranted to assess if anti-fungal therapy is an effective adjunctive treatment for axial spondyloarthropathy

NCT ID: NCT05118620 Withdrawn - Pain, Postoperative Clinical Trials

Pericapsular Nerve Group Block (PENG) for Hip Surgery

Start date: December 9, 2021
Phase: Phase 4
Study type: Interventional

This will be a randomized comparison of pericapsular nerve group (PENG) blocks with bupivacaine and a placebo control (PENG blocks with normal saline). The overall objective of the proposed research is to determine the relative risks and benefits of a single-injection PENG block to provide postoperative analgesia following hip arthroscopy. Hypothesis 1: Following hip arthroscopy, participants with a PENG block will experience less pain in the recovery room compared with current standard-of-care as measured with the Numeric Rating Scale (NRS). Hypothesis 2: Following hip arthroscopy, participants with a PENG block will consume less opioid in the operating and recovery rooms compared with current standard-of-care as measured in oral morphine milligram equivalents. Primary end point: In order to claim that PENG blocks are superior to placebo overall, at least one of these two hypotheses must demonstrate PENG superiority while the other cannot demonstrate inferiority.

NCT ID: NCT05116800 Withdrawn - Soft Tissue Sarcoma Clinical Trials

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Start date: March 1, 2022
Phase: Phase 2
Study type: Interventional

This is an open label, two-stratum, phase 2 clinical trial evaluating the efficacy of 9-ING-41 in combination with gemcitabine/docetaxel in patients ≥10 years of age with advanced sarcoma. 9-ING-41 in combination with gemcitabine and docetaxel will lead to sustained disease control and/or increase the rates of objective response in patients with unresectable or metastatic soft tissue and bone sarcomas.

NCT ID: NCT05116618 Withdrawn - Clinical trials for Non-Small Cell Lung Cancer

Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

Start date: January 6, 2022
Phase:
Study type: Observational

To determine the detection rate of driver oncogenes and resistance mechanisms in cerebrospinal fluid (CSF) for patients with CNS progression (with or without extra-CNS (eCNS) progression) and concordance with plasma/tissue

NCT ID: NCT05112874 Withdrawn - Clinical trials for SARS-CoV-2 Infection

ImmuneSense™ COVID-19 Cross-Reactivity Study

Start date: December 15, 2021
Phase:
Study type: Observational

Adaptive Biotechnologies has developed a clinical test called T-Detect COVID Test that can identify a T-cell response to the SARS-CoV-2 virus, indicating recent or prior infection This study aims to evaluate the potential cross-reactivity of the T-Detect COVID test in participants presenting with viral upper respiratory tract infections within the assay's intended use population and testing positive for seasonal coronavirus.